Login
Search
Search
0 Dates
2026
2025
2024
2023
2022
2021
2020
2019
2018
0 Events
CPC 2018
CPC 2019
Curso de Atualização em Medicina Cardiovascular 2019
Reunião Anual Conjunta dos Grupos de Estudo de Cirurgia Cardíaca, Doenças Valvulares e Ecocardiografia da SPC
CPC 2020
CPC 2021
CPC 2022
CPC 2023
CPC 2024
CPC 2025
CPC 2026
0 Topics
A. Basics
B. Imaging
C. Arrhythmias and Device Therapy
D. Heart Failure
E. Coronary Artery Disease, Acute Coronary Syndromes, Acute Cardiac Care
F. Valvular, Myocardial, Pericardial, Pulmonary, Congenital Heart Disease
G. Aortic Disease, Peripheral Vascular Disease, Stroke
H. Interventional Cardiology and Cardiovascular Surgery
I. Hypertension
J. Preventive Cardiology
K. Cardiovascular Disease In Special Populations
L. Cardiovascular Pharmacology
M. Cardiovascular Nursing
N. E-Cardiology / Digital Health, Public Health, Health Economics, Research Methodology
O. Basic Science
P. Other
0 Themes
01. History of Cardiology
02. Clinical Skills
03. Imaging
04. Arrhythmias, General
05. Atrial Fibrillation
06. Supraventricular Tachycardia (non-AF)
07. Syncope and Bradycardia
08. Ventricular Arrhythmias and Sudden Cardiac Death (SCD)
09. Device Therapy
10. Chronic Heart Failure
11. Acute Heart Failure
12. Coronary Artery Disease (Chronic)
13. Acute Coronary Syndromes
14. Acute Cardiac Care
15. Valvular Heart Disease
16. Infective Endocarditis
17. Myocardial Disease
18. Pericardial Disease
19. Tumors of the Heart
20. Congenital Heart Disease and Pediatric Cardiology
21. Pulmonary Circulation, Pulmonary Embolism, Right Heart Failure
22. Aortic Disease
23. Peripheral Vascular and Cerebrovascular Disease
24. Stroke
25. Interventional Cardiology
26. Cardiovascular Surgery
27. Hypertension
28. Risk Factors and Prevention
29. Rehabilitation and Sports Cardiology
30. Cardiovascular Disease in Special Populations
31. Pharmacology and Pharmacotherapy
32. Cardiovascular Nursing
33. e-Cardiology / Digital Health
34. Public Health and Health Economics
35. Research Methodology
36. Basic Science
37. Miscellanea
0 Resources
Abstract
Slides
Vídeo
Report
CLEAR FILTERS
Not All LBBB Are Equal: Impact of LBBB Morphology and Super-Response in CRT Patients
Session:
Sessão de Posters 20 - Gestão moderna de arritmias: do mapeamento à monitorização
Speaker:
Joana Simões de Azevedo Massa Pereira
Congress:
CPC 2026
Topic:
C. Arrhythmias and Device Therapy
Theme:
09. Device Therapy
Subtheme:
09.3 Cardiac Resynchronization Therapy
Session Type:
Posters Eletrónicos
FP Number:
---
Authors:
Joana Massa Pereira; Sofia Andraz; Lucas Hamann; Joana Guerreiro Pereira; Daniela Carvalho; Raquel Fernandes; João Sousa Bispo; Dina Bento; Pedro Azevedo; Rui Candeias; Hugo Alex Costa; Jorge Mimoso
Abstract
<p style="text-align:justify"><span style="font-size:11pt"><span style="font-family:Aptos,sans-serif"><strong><span style="font-size:10.0pt">Introduction: </span></strong><span style="font-size:10.0pt">One of the most potent predictors of cardiac resynchronization therapy (CRT) benefit is the presence of left bundle branch block (LBBB). Differences in LBBB morphology - i.e, true complete LBBB (tcLBBB) due to conduction system degeneration or LBBB like pattern (lpLBBB) with conduction delay reflecting myocardial pathology - are often seen in the clinical setting and may impact response to CRT. Although, an association with LBBB morphology and response/super-response to CRT is not fully established. </span></span></span></p> <p style="text-align:justify"><span style="font-size:11pt"><span style="font-family:Aptos,sans-serif"><strong><span style="font-size:10.0pt">Objective: </span></strong><span style="font-size:10.0pt">To assess the association LBBB morphology/pattern and super-response in CRT patients. </span></span></span></p> <p style="text-align:justify"><span style="font-size:11pt"><span style="font-family:Aptos,sans-serif"><strong><span style="font-size:10.0pt">Methods: </span></strong><span style="font-size:10.0pt">A retrospective analysis between 2020 and 2023 included 95 patients who underwent CRT implantation. Collected data included demographics, cardiovascular risk factors and echocardiographic </span><span style="font-size:10.0pt">and electrocardiographic parameters. Super-response to CRT was defined as an absolute increase in left ventricular ejection fraction (LVEF) ≥ 10% and/or ≥ 30% reduction in left ventricular end-systolic volume and/or ≥ 20% reduction in left ventricular end-diastolic volume (LVEDV). Patients were classified according to LBBB morphology (lpLBBB vs tcLBBB). LBBB European Society of Cardiology criteria was used to identify tcLBBB morphology. Predictors of super-response were identified using multivariate logistic regression.</span></span></span></p> <p style="text-align:justify"><span style="font-size:11pt"><span style="font-family:Aptos,sans-serif"><strong><span style="font-size:10.0pt">Results: </span></strong><span style="font-size:10.0pt">The final cohort consisted of 88 patients, of whom 51 (58%) with lpLBBB and 37 (42%) with tcLBBB. The mean age was 69.5±10.4 years, with 77.3% being male. Mean baseline QRS duration was 166±24ms, with a wider QRS at baseline in tcLBBB (178±21ms, p=0.006). Mean biventricular pacing was 95.9%, without differences between groups. QRS reduction ≥ 26ms (51.4%, p<0.001), baseline LBBB > 150ms (98.8%, p=0.001), use of mineralocorticoids receptor antagonists drugs (81.1%, p=0.047), QRS variation (28.2±20.5, p<0.001) and the degree of LVEF improvement (29.7% --> 44.2%, p=0.001) and LVEDV reduction (210ml --> 159ml, p=0.006) were more frequent among tcLBBB. CRT super-response occurred in 23 patients (39.7%), significantly more frequent in tcLBBB (62.5%, p=0.003). tcLBBB independently predicted super-response, increasing the likelihood by 21-fold (OR=21.54, p=0.015). Other predictors were QRS variation ≥ 26ms (OR=9.612, p=0.043), non-ischemic etiology (OR=20.14, p=0.009) and the use of ACEi (OR=15.16, p=0.022). </span></span></span></p> <p style="text-align:justify"><span style="font-size:11pt"><span style="font-family:Aptos,sans-serif"><strong><span style="font-size:10.0pt">Conclusions: </span></strong><span style="font-size:10.0pt">In this cohort, tcLBBB morphology prior to CRT implantation was associated/predictor with more pronounced reverse remodeling, as reflected by improvements in LVEF, LVEDV, and super-response rates during medium- to long-term follow-up. These findings reinforce the concept that tcLBBB morphology is an important and specific surrogate of LV electrical activation and response to resynchronization. Further studies are needed to confirm these findings and determine their impact on hard clinical outcomes.</span></span></span></p>
Slides
Our mission: To reduce the burden of cardiovascular disease
Visit our site